Skip to content

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05750381
Enrollment
20
Registered
2023-03-01
Start date
2023-01-24
Completion date
2023-04-12
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microbial Colonization

Keywords

probiotic

Brief summary

The purpose of this study is to evaluate the skin quality improvement and colonization efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the elbow and back of forearm in a topical balm format in healthy adults.

Detailed description

This is a randomized double-blind, placebo-controlled pilot study with no crossover for the assessment of any changes to the microbial make-up of the skin (The local skin microbiome), detection of colonisation by the probiotic bacterium (BLIS Q24) on the skin and to evaluate the changes in skin quality parameters following topical application of probiotic in a balm format.

Interventions

OTHERMicrococcus luteus Blis Q24 balm

Balm formulation containing probiotic bacteria Micrococcus luteus Q24 for topical applications.

Placebo balm formulation for topical applications.

Sponsors

BLIS Technologies Limited
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Masking description

A Staff member, not part of the study group will be assigned to distribute blinded samples. The investigator will not be are of the dose groups.

Intervention model description

Participants will be randomly assigned to one of two groups applying balm containing Micrococcus luteus Q24 or placebo balm. Group A: Probiotic Micrococcus luteus Q24 balm (dose:1e7 colony forming units per application of balm). Group B: Placebo balm (dose:0 colony forming units per application of balm).

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* In general good health 18 - 80 years of age. * Practice good general body hygiene

Exclusion criteria

* Have a history of autoimmune disease or are immunocompromised. * Are on concurrent antibiotic therapy or regular antibiotic use within the last 1 week. * People with allergies or sensitivity to dairy. * People with an open wound on the Blis Q24 application sites.

Design outcomes

Primary

MeasureTime frameDescription
Change in microbial composition on skin following application of Micrococcus luteus Q24 in balm from Day 0 (baseline) to 11 days11 days post interventionStudy will determine the change in microbial composition following the application of a balm containing Micrococcus luteus Q24 balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin swab data from baseline to 11 days across two different sites with a level of significance of p\<0.05. Overall colonization based on percentage of population colonized for different interventions will also be analyzed using appropriate statistical analysis software.
Change in skin quality parameters following topical application of placebo balm from Day 0 (baseline) to 11 days11 days post last interventionStudy will determine the change in skin quality parameters using a skin quality analyzer following topical application of placebo balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin quality data from baseline to 11 days across two different sites with a level of significance of p\<0.05.
Change in microbial composition on skin following application of placebo balm from Day 0 (baseline) to 11 days11 days post interventionStudy will determine the change in microbial composition following the application of a placebo balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin swab data from baseline to 11 days across two different sites with a level of significance of p\<0.05. Overall colonization based on percentage of population colonized for different interventions will also be analyzed using appropriate statistical analysis software.
Change in microbial composition on skin post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.7 days post last interventionStudy will determine the change in microbial composition post 10 days application of Micrococcus luteus Q24 at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin swab data from Day 11 to 18 days across two different sites with a level of significance of p\<0.05. Overall colonization based on percentage of population colonized for different interventions will also be analyzed using appropriate statistical analysis software.
Change in microbial composition on skin post 10 day application application of placebo balm from Day 11 (baseline) to 18 days7 days post last interventionStudy will determine the change in microbial composition following the application of a placebo balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin swab data from Day 11 to 18 days across two different sites with a level of significance of p\<0.05. Overall colonization based on percentage of population colonized for different interventions will also be analyzed using appropriate statistical analysis software.
Change in skin quality parameters following topical application Micrococcus luteus Q24 from Day 0 (baseline) to 11 days11 days post last interventionStudy will determine the change in skin quality parameters using a skin quality analyzer following topical application of Micrococcus luteus Q24 balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin quality data from baseline to 11 days across two different sites with a level of significance of p\<0.05.
Change in skin quality parameters post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.7 days post last interventionStudy will determine the change in skin quality parameters using a skin quality analyzer following topical application of Micrococcus luteus Q24 balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin quality data from Day 11 to Day 18 across two different sites with a level of significance of p\<0.05.
Change in skin quality parameters post 10 days application of placebo balm from Day 11 (baseline) to 18 days.7 days post last interventionStudy will determine the change in skin quality parameters using a skin quality analyzer following topical application of placebo balm at two body sites (elbow and back of hand). The statistical analysis will be carried out to compare the participants skin quality data from Day 11 to Day 18 across two different sites with a level of significance of p\<0.05.

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026